Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10227375 Neuroactive steroids and methods of use thereof

Patent 10227375 was granted and assigned to SAGE Therapeutics on March, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10227375

Date of Patent

March 12, 2019

Patent Application Number

15917263

Date Filed

March 9, 2018

Patent Citations Received

‌

US Patent 12129276 Oxysterols and methods of use thereof

‌

US Patent 11905309 Neuroactive steroids and methods of use thereof

‌

US Patent 11926646 C7 substituted oxysterols and methods of use thereof

‌

US Patent 12129275 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 10696712 Oxysterols and methods of use thereof

‌

US Patent 10723758 Oxysterols and methods of use thereof

‌

US Patent 10752653 Oxysterols and methods of use thereof

‌

US Patent 10759828 Neuroactive steroids, compositions, and uses thereof

...

Patent Primary Examiner

‌

Barbara P Badio

Patent abstract

Compounds are provided according to Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10227375 Neuroactive steroids and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API